Clinical relevance of single item quality of life indicators in cancer clinical trials

British Journal of Cancer

Volumn 84, Issue 9, 2001, Pages 1156-1165

  Bernhard, J ^a   Sullivan, M ^b   Hurny C ^c   Coates, A S ^d   Rudenstam, C M ^b  

^a IBCSG Coordinating Center   (Switzerland)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Bürgerspital Rorschacher   (Switzerland)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breast cancer; Global indicators; Quality of life; Randomized controlled trials; Responsiveness; Scale comparison

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; GONADORELIN; METHOTREXATE; TAMOXIFEN;

ACCURACY; AFFECTIVE NEUROSIS; ARTICLE; BREAST CANCER; CLINICAL STUDY; CONTROLLED STUDY; EMOTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RELIABILITY; SELF EVALUATION; SOCIAL INTERACTION; SWEDEN; WELLBEING;

ADULT; AGED; BREAST NEOPLASMS; ENDPOINT DETERMINATION; FEMALE; HUMANS; MIDDLE AGED; MOOD DISORDERS; QUALITY OF LIFE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0035805029     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1785     Document Type: Article

References (36)

1. A comparison of overall health between patients with rheumatoid arthritis and a population with and without rheumatoid arthritis
2. Chronic pain in functional neurosurgery: Function and mood in various diagnostic groups with reference to epidural spinal electrical stimulation
3. The sSckness Impact Profile: Development and final revision of a health status measure
4. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: The IBCSG approach
5. Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: Formestane versus megestrol acetate as second-line hormonal treatment
6. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?
7. On the receiving end IV: Validation of quality of life indicators
8. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies
9. On the receiving end - III. Measurement of quality of life during cancer chemotherapy
10. Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer
11. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma
12. Single-item vs multiple-item measures of health-related quality of life
13. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial
14. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer?
15. Quality of life measures for patients receiving adjuvant therapy for breast cancer: An international trial
16. The perceived adjustment to chronic illness scale (PACIS): A global indicator of coping for operable breast cancer patients in clinical trials
17. Responsiveness of a single-item indicator versus a multi-item scale: Assessment of emotional well-being in an international adjuvant breast cancer trial
18. Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
19. Comparative measurement sensitivity of short and longer health status instruments
20. Comparisons of five health status instruments for orthopedic evaluation
21. Coping with chemotherapy for breast cancer
22. Anxiety and depression in breast cancer patients at start of adjuvant radiotherapy. Relations to age and type of surgery
23. Psychological distress after initial treatment of breast cancer
24. Randomized trial of a psychologic distress screening program after breast cancer: Effects on quality of life
25. Clinical applications of visual analogue scales: A critical review
26. The validity and relative precision of MOS Short- and Long-Form Health Status Scales and Dartmouth COOP charts: Results from the medical outcomes study
27. Evaluation of quality of life in patients receiving treatment for advanced breast cancer
28. The measurement of mood
29. Measuring health in rheumatic disorders by means of a Swedish version of the sickness impact profile
30. Swedish obese subjects (SOS) - An intervention study of obesity. Baseline evaluation of health and psychosocial functioning in the first 1743 subjects examined
31. Health complaints, stress, and distress: Exploring the central role of negative affectivity
32. Relationships between emotional control, adjustment to cancer and depression and anxiety in breast cancer patients
33. Clinical self-rating scales (CSRS) of the Munich Psychiatric Information System (PSYCHIS München)
34. The Hospital Anxiety and Depression Scale